An anti-cancer compound developed at USA Health Mitchell Cancer Institute is showing promise in pre-clinical studies – one involving pancreatic cancer and the other involving breast cancer. The compound, MCI-715, was developed by Gary Piazza, Ph.D., and his lab team at the Drug Discovery Research Center at MCI.
About USA Mobile Diagnostic Center
At USA Mobile Diagnostic Center, we are dedicated to the delivery of primary and specialty care. Our multispecialty group provides care to the people of Mobile and the central Gulf Coast. We specialize in the areas of internal medicine, rheumatology, diabetes management, gastroenterology and lipidology.
USA Mobile Diagnostic Center's hours of operation are Monday through Friday, 8 a.m. to 5 p.m.